Microbiota in patients with cefuroxime resistance and anal fistula revealed by 16S ribosomal DNA

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

383

Figures (1-4)

Tables (1-2)

Sum=551

Publishing Process of This Article

Item

Count

Browse

Download

Sum=69

Jan 27, 2025 (publication date) through Feb 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Surg. Jan 27, 2025; 17(1): 100790
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100790

Table 2 Comparison of outcomes before and after taking Clostridium butyricum tablets

Features	Before taking CBT	After taking CBT	Statistics	P value
Cefuroxime resistance (n)	9	2	-1.56	< 0.01
Defection frequency (times/day), mean ± SD	2.3 ± 1.2	1.7 ± 0.7	1.78	0.02
Stool consistency score, mean ± SD	19.3 ± 7.8	11.9 ± 8.1	-3.73	0.02

CBT: Clostridium butyricum tablets.

Citation: Ling YT, Yao F, Li SJ, Cao CX, Chen ZW, Qiu M, Li BZ, Hu BW, Zhong SY, Hu GL, Li JH. Microbiota in patients with cefuroxime resistance and anal fistula revealed by 16S ribosomal DNA. World J Gastrointest Surg 2025; 17(1): 100790
URL: https://www.wjgnet.com/1948-9366/full/v17/i1/100790.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.100790